Дисфункция респираторных мышц и болезни органов дыхания
________________________________________________
Geltser B.I., Kurpatov I.G., Dej A.A., Kozhanov A.G. Respiratory muscles dysfunction and respiratory diseases. Therapeutic Archive. 2019; 91 (3): #–100. DOI: 10.26442/00403660.2019.03.000108
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: обзор, дисфункция респираторных мышц, болезни органов дыхания.
________________________________________________
This review presents an analysis of the literature on the topic of respiratory muscle (RM) dysfunction in various forms of respiratory pathology: chronic obstructive pulmonary disease (COPD), asthma, community-acquired pneumonia, idiopathic pulmonary fibrosis (IPF), sarcoidosis and interstitial lung diseases (ILD), associated with systemic connective tissue diseases (polymyositis, dermatomyositis and systemic lupus erythematosus – SLE). Various clinical and pathophysiological aspects of RM dysfunction and general patterns of its pathogenesis were examined. It was proved that the role of RM in the development of respiratory failure depends on the form and stage of the pulmonary pathology and the severity of systemic manifestations of these diseases: excessive proteolysis, oxidative stress, hypoxia, chronic systemic inflammation. These factors modify the morphofunctional status of RM, worsens their contractile function, which is contributed to the development of respiratory failure. In some cases, the primary weakness of RM precedes the clinical manifestation of pulmonary pathology, which is distinctive for some variants of myositis-associated ILD and SLE. Endogenous intoxication syndrome plays a significant role in the development of RM dysfunction during community-acquired pneumonia. It is noted that sarcoid pulmonary ventilation disorders associate with the RM weakness, but not with the degree of lung damage. In most cases, secondary RM dysfunction predominates that contributes to respiratory failure progression, which is especially noticeable in case of COPD, asthma and IPF.
Keywords: overview, respiratory muscles dysfunction, respiratory diseases.
2. Александрова Н.П. Цитокины и резистивное дыхание. Физиология человека. 2012;38(2):119-29 [Aleksandrova NP. Cytokines and Resistive Breathing. Human physiology. 2012;38(2):119-29 (In Russ.)]. http://dx.doi.org/10.1134/s0362119712020028
3. Чучалин А.Г., Айсанов З.Р. Нарушение функции дыхательных мышц при хронических обструктивных заболеваниях легких. Терапевтический архив. 1988;60(7):126-31 [Chuchalin AG, Aisanov ZR. Respiratory muscles disturbances associated with chronic obstructive pulmonary diseases. Therapeutic Archive. 1988;60(7):126-31 (In Russ.)].
4. Lumb AB. Nunn's Applied Respiratory Physiology eBook. Elsevier Health Sciences. 2016.
5. O’Donnell DE, Laveneziana P, Webb K, Neder JA. Chronic obstructive pulmonary disease: clinical integrative physiology. Clinics in chest medicine. 2014;35(1):51-69. Available at: http://svmi.web.ve/wh/ intertips/2.EPOC-FISIOPATOLOGIA.pdf
6. Елисеев В.А. Комплексное лечение больных рецидивирующим бронхитом в фазе ремиссии: автореф. дис…. д.м.н. Барнаул, 2015. Доступно по: http://medical-diss.com/medicina/kompleksnoe-lechenie-bolnyh-retsidiviruyuschim-bronhitom-v-faze-rem... [Eliseev VA. Сombination therapy of patient with recurrent bronchitis in phase of remission. [dissertation]. Barnaul, 2015 (In Russ.)]. Available at: http://medical-diss.com/medicina/kompleksnoe-lechenie-bolnyh-retsidiviruyuschim-bronhitom-v-faze-rem...
7. Пономарева И.Б. Клиническая оценка силы и выносливости дыхательной мускулатуры у больных хронической обструктивной болезнью легких старческого возраста: дис. … к.м.н. Рязань, 2010. Доступно по: http://medical-diss.com/medicina/klinicheskaya-otsenka-sily-i-vynoslivosti-dyhatelnoy-muskulatury-u-... [Ponomareva IB. Clinical evaluation of strength and endurance of respiratory muscles in the group of eldery patients with chronic obstructive pulmonary disease [dissertation]. Ryazan, 2010 (In Russ.)]. Available at: http://medical-diss.com/medicina/klinicheskaya-otsenka-sily-i-vynoslivosti-dyhatelnoy-muskulatury-u-...
8. Авдеев С.Н. Оценка силы дыхательных мышц в клинической практике. Практическая пульмонология. 2008;4:2-17. Доступно по: https://elibrary.ru/download/elibrary_11699679_50507638.pdf [Avdeev SN. Assessment of the strength of the respiratory muscles in clinical practice. Practical pulmonology. 2008;4:2-17 (In Russ.)]. Available at: https://elibrary.ru/download/elibrary_11699679_50507638.pdf
9. Kaminska M, Noel F, Petrof BJ. Optimal method for assessment of respiratory muscle strength in neuromuscular disorders using sniff nasal inspiratory pressure (SNIP). PLOS ONE. 2017;12(5):e0177723. http://dx.doi.org/10.1371/journal.pone.0177723
10. Fernandes M, Cukier A, Ambrosino N, Leite JJ, Zanetti Feltrim MI. Respiratory pattern, thoracoabdominal motion and ventilation in chronic airway obstruction. Monaldi Archives for Chest Disease. 2016;67(4):209-16. http://dx.doi.org/10.4081/monaldi.2007.477
11. Sharp JT, Hyatt RE. Mechanical and Electrical Properties of Respiratory Muscles. Comprehensive Physiology. 2011;3:1553-67. http://dx.doi.org/10.1002/cphy.cp030323
12. Платонова И.С. Морфологические изменения дыхательных мышц у больных хронической обструктивной болезнью легких с разной степенью дыхательной недостаточностью: дис. … к.м.н. СПб., 2003. Доступно по: http://www.fesmu.ru/elib/Article.aspx?id=123714 [Platonova IS. Morphological changes of respiratory muscles in the group of chronic obstructive pulmonary disease patients with varying degrees of respiratory insufficiency [dissertation]. Saint Petersburg, 2003 (In Russ.)]. Available at: http://www.fesmu.ru/elib/Article.aspx?id=123714
13. Сегизбаева М.О., Александрова Н.П. Оценка устойчивости разных групп инспираторных мышц к утомлению при физической нагрузке на фоне моделируемой обструкции дыхательных путей. Физиология человека. 2014;40(6):114-22 [Segizbaeva MO, Aleksandrova NP. Inspiratory muscle resistance to fatigue during exercise and simulated airway obstruction. Human Physiology. 2014;40(6):114-22 (In Russ.)]. http://dx.doi.org/10.7868/ s0131164614050130
14. Mathur S, Brooks D, Carvalho CRF. Structural alterations of skeletal muscle in copd. Frontiers in Physiology. 2014;104(5):1-8. http://dx.doi.org/10.3389/fphys.2014.00104
15. Gea J, Agusti A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Applied Physiology. 2013;114(9):1222-34. http://dx.doi.org/ 10.1152/japplphysiol.00981.2012
16. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013;280(17):4294-314. http://dx.doi.org/10.1111/febs.12253
17. Суханова Г.И., Киняйкин М.Ф., Рассохина Н.Ю., Крамар А.В. Роль гипоксемии в развитии дисфункции мускулатуры верхних конечностей при хронической обструктивной болезни легких. Тихоокеанский медицинский журнал. 2012;1(47):90-2. Доступно по: https://elibrary.ru/item.asp?id=22670355 [Sukhanova GI, Kinyaikin MF, Rassokhina NYu, Kramar AV. Role of hypoxemia in formation of upper limb muscle dysfunction in case of chronic obstructive lung disease. Pacific medical journal. 2012;1(47):90-2 (In Russ.)]. Available at: https://elibrary.ru/item.asp?id=22670355
18. Remels AHV, Gosker HR, Langen RCJ, Schols AMWJ. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Applied Physiology. 2012;114(9):1253-62. http://dx.doi.org/10.1152/japplphysiol. 00790.2012
19. Ciciliot S, et al. Muscle type and fiber type specificity in muscle wasting. The International J Biochemistry & Cell Biology. 2013;45(10):2191-9. http://dx.doi.org/10.1016/j.biocel.2013.05.016
20. Clanton TL, Levine S. Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? J Applied Physiology. 2009;107(1):324-35. http://dx.doi.org/10.1152/japplphysiol.00173.2009
21. Barreiro E, Gea J. Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease. Chronic Respiratory Disease. 2016;13(3):297-311. http://dx.doi.org/10.1177/147 9972316642366
22. Cojocaru C, et al. A biological perspective for the management of chronic obstructive pulmonary disease by testosterone. Archives of Biological Sciences. 2015;67(1):257-9. http://www.doiserbia.nb.rs/img/ doi/0354-4664/2015/0354-46641400035C.pdf
23. Гончаров Н.П., Кация Г.В. Дегидроэпиандростерон: биосинтез, метаболизм, биологическое действие и клиническое применение (аналитический обзор). Андрология и генитальная хирургия. 2015;16(1):13-22 [Goncharov NP, Katsiya GV. Dehydroepiandrosterone biosynthesis, metabolism, biological effects, and clinical use (analytical review). Andrology and Genital Surgery. 2015;16(1):13-22 (In Russ.)]. doi: 10.17650/2070-9781-2015-1-13-22
24. Levin OS, Polunina AG, Demyanova MA, Isaev FV. Steroid myopathy in patients with chronic respiratory diseases. J Neurological Sciences. 2014;338(1-2):96-101. http://dx.doi.org/10.1016/j.jns.2013.12. 023
25. Mantilla CB, Sieck GC. Impact of diaphragm muscle fiber atrophy on neuromotor control. Respiratory Physiology & Neurobiology. 2013;189(2):411-8. http://dx.doi.org/10.1016/j.resp.2013.06.025
26. Laveneziana P, Webb KA, Wadell K, Neder JA, O’Donnell DE. Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD? Respiratory Physiology & Neurobiology. 2014;199:24-33. http://dx.doi.org/10.1016/j.resp.2014.04.005
27. Weatherald J, Lougheed MD, Taillé C, Garcia G. Mechanisms, measurement and management of exertional dyspnoea in asthma. European Respiratory Review. 2017;26(144):170015. http://dx.doi.org/ 10.1183/16000617.0015-2017
28. Мухарлямов Ф.Ю., Сычева М.Г., Рассулова М.А. Тренировка дыхательных мышц по методу нормокапнической гипервентиляции у больных хронической обструктивной болезнью легких и бронхиальной астмой. Вестник Национального медико-хирургического центра им. Н.И. Пирогова. 2015;10(3):109-12. Доступно по: https://elibrary.ru/download/elibrary_26508445_19489 114.pdf [Moukharliamov FYu, Sytcheva MG, Rassulova MA. Training of respiratory muscles on the normocapnic hyperventilation method at patients with the chronic obstructive lung disease and bronchial asthma. Bulletin of Pirogov National Medical & Surgical Center. 2015;10(3):109-12 (In Russ.)]. Available at: https://elibrary.ru/download/elibrary_2650 8445_19489 114.pdf
29. Баркова А.В. и др. Параметры активности местного и системного воспаления у больных бронхиальной астмой женщин вне обострения заболевания. Ученые записки СПбГМУ им. акад. И.П. Павлова. 2016;23(3):47-51. Доступно по: https://elibrary.ru/download/elibrary_ 28361330_96401650.pdf [Barkova AV, et al. Parameters of activity of local and systemic inflammation in patients with bronchial asthma women without exacerbation of the disease. Uchenye zapiski Saint Petersburgskogo gosudarstvennogo medicinskogo universiteta imeni akademika IP. Pavlova. 2016;23(3):47-51 (In Russ.)]. Available at: https://elibrary.ru/download/elibrary_28361330_96401650.pdf
30. Pereira LFF, Mancuzo EV, Rezende CF, Côrrea RA. Six-minute walk test and respiratory muscle strength in patients with uncontrolled severe asthma: a pilot study. J Brasileiro de Pneumologia. 2015;41(3):211-8. http://dx.doi.org/10.1590/s1806-37132015000004483
31. Ramos E, de Oliveira LV, Silva A, Costa I, Corrêa JC, Costa D, et al. Peripheral muscle strength and functional capacity in patients with moderate to severe asthma. Multidisciplinary Respiratory Medicine. 2015;10(1):3-10. http://dx.doi.org/10.1186/2049-6958-10-3
32. Aguiar KA, et al. A single section of stretch of the respiratory muscles does not influence the pulmonary volume of asthmatics during exercise. J Respiratory and Cardiovascular Physical Therapy. 2016;3(1):3-13. Available at: https://www.researchgate.net/profile/ntonio_Sarmento3/publication/301541319_A_Single_Section_of_Stre...
33. Gimeno-Santos E, Fregonezi GA, Torres-Castro R, Rabinovich R, Vilaró J. Inspiratory muscle training and exercise versus exercise alone for asthma. Cochrane Database of Systematic Reviews. 2015;7:1-10. http://dx.doi.org/10.1002/14651858.cd011794
34. Kuznetsov NA, Luberto CM, Avallone K, Kraemer K, McLeish AC, Riley MA. Characteristics of postural control among young adults with asthma. J Asthma. 2014;52(2):191-7. http://dx.doi.org/10.3109/ 02770903.2014.954290
35. Bodine SC, Furlow JD. Glucocorticoids and Skeletal Muscle. Glucocorticoid Signaling. 2015:145-76. Available from: http://dx.doi.org/ 10.1007/978-1-4939-2895-8_7
36. Полунина А.Г., Исаев Ф.В., Демьянова М.А. Стероидная миопатия. Журнал неврологии и психиатрии им. С.С. Корсакова. 2012;112(10):60-4. Доступно по: https://www.researchgate.net/profile/Anna_Polunina/publication/233949279_Steroidnaa_miopatia/links/0... [Polunina AG, Isaev FV, Demianova MA. Steroid-induced myopathy. Neuroscience and behavioral physiology. 2012;112(10):60-4 (In Russ.)]. Available at: https://www.researchgate.net/profile/Anna_Polunina/publication/233949279_Steroidnaa_miopatia/links/0...
37. Teodorescu M, Xie A, Sorkness CA, Robbins J, et al. Effects of Inhaled Fluticasone on Upper Airway during Sleep and Wakefulness in Asthma: A Pilot Study. J Clinical Sleep Medicine. 2014;10(2):183-93. http://dx.doi.org/10.5664/jcsm.3450
38. Qiao H, Cheng H, Liu L, Yin J. Potential factors involved in the causation of rhabdomyolysis following status asthmaticus. Allergy, Asthma & Clinical Immunology. 2016;12(1):1-7. http://dx.doi.org/10.1186/ s13223-016-0149-6
39. He Y, Shi J, Yi W, Ren X, et al. Discovery of a highly potent glucocorticoid for asthma treatment. Cell Discovery. 2016;2:150-63. http://dx.doi.org/10.1038/celldisc.2015.51
40. Verschakelen J, Vock P. Diseases of the Chest Wall, Pleura, and Diaphragm. Diseases of the Heart, Chest & Breast. 2015:99-103. http://dx.doi.org/10.1007/978-88-470-0633-1_17
41. Tochino Y, et al. Asthma‐COPD overlap syndrome—Coexistence of chronic obstructive pulmonary disease and asthma in elderly patients and parameters for their differentiation. J General and Family Medicine. 2017;18(5):5-11. Available at: http://onlinelibrary.wiley.com/ doi/10.1002/jgf2.2/epdf
42. José A, Dal Corso S. Inpatient rehabilitation improves functional capacity, peripheral muscle strength and quality of life in patients with community-acquired pneumonia: a randomised trial. J Physiotherapy. 2016;62(2):96-102. http://dx.doi.org/10.1016/j.jphys. 2016.02.014
43. Агеева Т.С. и др. Клинико-сцинтиграфическая характеристика и окислительные процессы в зависимости от распространенности инфильтративного поражения легочной ткани при внебольничных пневмониях. Терапевтический архив. 2011;83(3):31-7. Доступно по: https://elibrary.ru/item.asp?id=16373885 [Ageeva TS, et al. Clinico-scintigraphic characteristics and oxidation in community-acquired pneumonia: correlations with severity of pulmonary tissue infiltrative lesion. Therapeutic Archive. 2011;83(3):31-7 (In Russ.)]. Available at: https://elibrary.ru/item.asp?id=16373885
44. Гельцер Б.И., Ким А.П., Котельников В.Н., Макаров А.Б. Особенности иммунного ответа у больных внебольничной пневмонией с разной степенью тяжести эндогенной интоксикации. Цитокины и воспаление. 2015;14(3):35-41. Доступно по: https://elibrary.ru/item.asp?id=26511105 [Geltser BI, Kim AP, Kotelnikov VN, Makarov AB. Features of immune response in patients with community-acquired pneumonia with endogenous intoxication of different degrees of severity. Cytokines and Inflammation. 2015;14(3):35-41 (In Russ.)]. Available at: https://elibrary.ru/item.asp?id=26511105
45. Сомов Д.А., Макарова М.Р., Макарова И.Н. Значение мышечного дисбаланса в двигательной терапии больных пневмонией. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2015;92(3):7-10. Доступно по: https://www.mediasphera.ru/issues/ voprosy-kurortologii-fizioterapii-i-lechebnoj-fizicheskoj-kultury/2015/3/ downloads/ru/030042-8787201532 [Somov DA, Makarova MR, Makarova IN. The importance of muscular disbalance for the development of the system of therapeutic physicalexercises to treat the patients presenting with pneumonia. Voprosy kurortologii, fizioterapii i lechebnoy fizicheskoy kul’tury. 2015;92(3):7-10 (In Russ.)]. Available at: https://www.mediasphera.ru/issues/voprosy-kurortologii-fizioterapii-i-lechebnoj-fizicheskoj-kultury/...
46. Musher DM, Thorner AR. Community-acquired pneumonia. New England J Medicine. 2014;371(17):1619-28. doi: 10.1056/NEJ Mra1312885
47. Faverio P, et al. The management of community-acquired pneumonia in the elderly. Eur J Intern Med. 2014;25(4):312-9. http:// dx.doi.org/10. 1016/j.ejim.2013.12.001
48. Murad A, Li PZ, Dial S, Shahin J. The role of noninvasive positive pressure ventilation in community-acquired pneumonia. J Critical Care. 2015;30(1):49-54. http://dx.doi.org/10.1016/j.jcrc.2014. 09.021
49. Faisal A, Alghamdi BJ, Ciavaglia CE, Elbehairy AF, Webb KA, Ora J, et al. Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders. Amer J Respiratory and Critical Care Medicine. 2016;193(3):299-309. http://dx.doi.org/10.1164/rccm.201504-0841oc
50. Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y, et al. Prognostic Factors for Myositis-Associated Interstitial Lung Disease. PLoS ONE. 2014;9(6):e98824. http://dx.doi.org/10.1371/journal. pone.0098824
51. Антелава О.А., Бондаренко И.Б., Чичасова Н.В., Насонов E.L. Респираторные нарушения при полимиозите/ дерматомиозите. Современная ревматология. 2014;8(1):31-8 [Antelava OA, Bondarenko IB, Chichasova NV, Насонов EL. Respiratory disorders in patients with polymyositis/ dermatomyositis. Modern Rheumatology J. 2014;8(1):31-8 (In Russ.)]. http://dx.doi.org/10.14412/1996-7012-2014-1-31-38
52. Rygiel KA, Miller J, Grady JP, Rocha MC, et al. Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathology and Applied Neurobiology. 2015;41(3):288-303. http://dx.doi.org/10.1111/nan.12149
53. Carstens PO, Schmidt J. Diagnosis, pathogenesis and treatment of myositis: recent advances. Clinical & Experimental Immunology. 2014;175(3):349-58. http://dx.doi.org/10.1111/cei.12194
54. Walterspacher S, Schlager D, Walker DJ, Müller-Quernheim J, Windisch W, Kabitz H-J. Respiratory muscle function in interstitial lung disease. European Respiratory J. 2012;42(1):211-9. http://dx.doi.org/10. 1183/09031936.00109512
55. Elia D, Kelly JL, Martolini D, Renzoni EA, Boutou AK, Chetta A, et al. Respiratory Muscle Fatigue following Exercise in Patients with Interstitial Lung Disease. Respiration. 2013;85(3):220-7. http://dx.doi.org/10.1159/ 000338787
56. Güttsches AK, Balakrishnan-Renuka A, Kley RA, Tegenthoff M, et al. ATOH8: a novel marker in human muscle fiber regeneration. Histochemistry and Cell Biology. 2014;143(5):443-52. http://dx.doi.org/ 10.1007/s00418-014-1299-6
57. Andrews JS, Trupin L, Schmajuk G, Barton J, et al. Muscle Strength, Muscle Mass, and Physical Disability in Women With Systemic Lupus Erythematosus. Arthritis Care & Research. 2014;67(1):120-7. http://dx. doi.org/10.1002/acr.22399
58. Mittoo S, Swigris JJ. Pulmonary Manifestations of Systemic Lupus Erythematosus (SLE). Pulmonary Manifestations of Rheumatic Disease. 2014;35(2):61-72. http://dx.doi.org/10.1007/978-1-4939-0770-0_6
59. Panagiotou M, Polychronopoulos V, Strange C. Respiratory and lower limb muscle function in interstitial lung disease. Chronic Respiratory Disease. 2016;13(2):162-72. http://dx.doi.org/10.1177/1479972315626 014
60. Авдеев С.Н. Идиопатический фиброз легких: новая парадигма. Терапевтический архив. 2017;89(1):112-22 [Avdeev SN. Idiopathic pulmonary fibrosis. Therapeutic Archive. 2017;89(1):112-22 (In Russ.)]. http://dx.doi.org/10.26442/20 75- 1753_19.3.17-23
61. Marcellis RGJ, Lenssen AF, Elfferich MDP, De Vries J, et al. Exercise capacity, muscle strength and fatigue in sarcoidosis. European Respiratory J. 2011;38(3):628-34. http://dx.doi.org/10.1183/0903 1936.00117710
62. Kesici B, Toros AB, Bayraktar L, Dervisoglu A. Sarcoidosis Incidentally Diagnosed: A Case Report. Case Reports in Pulmonology. 2014;2014:1-3. http://dx.doi.org/10.1155/2014/702868
63. Nowinski A, et al. Comorbidities associated with sarcoidosis–Results from long-term observational study. European Respiratory J. 2014;44(58):461. Available at: http://erj.ersjournals.com/content/44/ Suppl_58/P461.short
64. Celada LJ, Hawkins C, Drake WP. The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis. Clinics in Chest Medicine. 2015;36(4):561-8. http://dx.doi.org/10.1016/j.ccm.2015.08.001
________________________________________________
1. Aleksandrova NP, Breslav IS. Human respiratory muscle: 3 levels of control. Human physiology. 2009;35(2):103-11 (In Russ.). Available at: https://elibrary.ru/download/elibrary_13066881_12873971.pdf
2. Aleksandrova NP. Cytokines and Resistive Breathing. Human physiology. 2012;38(2):119-29 (In Russ.). http://dx.doi.org/10.1134/s0362119712020028
3. Chuchalin AG, Aisanov ZR. Respiratory muscles disturbances associated with chronic obstructive pulmonary diseases. Therapeutic Archive. 1988;60(7):126-31 (In Russ.).
4. Lumb AB. Nunn's Applied Respiratory Physiology eBook. Elsevier Health Sciences. 2016.
5. O’Donnell DE, Laveneziana P, Webb K, Neder JA. Chronic obstructive pulmonary disease: clinical integrative physiology. Clinics in chest medicine. 2014;35(1):51-69. Available at: http://svmi.web.ve/wh/ intertips/2.EPOC-FISIOPATOLOGIA.pdf
6. Eliseev VA. Сombination therapy of patient with recurrent bronchitis in phase of remission. [dissertation]. Barnaul, 2015 (In Russ.). Available at: http://medical-diss.com/medicina/kompleksnoe-lechenie-bolnyh-retsidiviruyuschim-bronhitom-v-faze-rem...
7. Ponomareva IB. Clinical evaluation of strength and endurance of respiratory muscles in the group of eldery patients with chronic obstructive pulmonary disease [dissertation]. Ryazan, 2010 (In Russ.). Available at: http://medical-diss.com/medicina/klinicheskaya-otsenka-sily-i-vynoslivosti-dyhatelnoy-muskulatury-u-...
8.Avdeev SN. Assessment of the strength of the respiratory muscles in clinical practice. Practical pulmonology. 2008;4:2-17 (In Russ.). Available at: https://elibrary.ru/download/elibrary_11699679_50507638.pdf
9. Kaminska M, Noel F, Petrof BJ. Optimal method for assessment of respiratory muscle strength in neuromuscular disorders using sniff nasal inspiratory pressure (SNIP). PLOS ONE. 2017;12(5):e0177723. http://dx.doi.org/10.1371/journal.pone.0177723
10. Fernandes M, Cukier A, Ambrosino N, Leite JJ, Zanetti Feltrim MI. Respiratory pattern, thoracoabdominal motion and ventilation in chronic airway obstruction. Monaldi Archives for Chest Disease. 2016;67(4):209-16. http://dx.doi.org/10.4081/monaldi.2007.477
11. Sharp JT, Hyatt RE. Mechanical and Electrical Properties of Respiratory Muscles. Comprehensive Physiology. 2011;3:1553-67. http://dx.doi.org/10.1002/cphy.cp030323
12. Platonova IS. Morphological changes of respiratory muscles in the group of chronic obstructive pulmonary disease patients with varying degrees of respiratory insufficiency [dissertation]. Saint Petersburg, 2003 (In Russ.). Available at: http://www.fesmu.ru/elib/Article.aspx?id=123714
13. Segizbaeva MO, Aleksandrova NP. Inspiratory muscle resistance to fatigue during exercise and simulated airway obstruction. Human Physiology. 2014;40(6):114-22 (In Russ.). http://dx.doi.org/10.7868/ s0131164614050130
14. Mathur S, Brooks D, Carvalho CRF. Structural alterations of skeletal muscle in copd. Frontiers in Physiology. 2014;104(5):1-8. http://dx.doi.org/10.3389/fphys.2014.00104
15. Gea J, Agusti A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Applied Physiology. 2013;114(9):1222-34. http://dx.doi.org/ 10.1152/japplphysiol.00981.2012
16. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013;280(17):4294-314. http://dx.doi.org/10.1111/febs.12253
17.Sukhanova GI, Kinyaikin MF, Rassokhina NYu, Kramar AV. Role of hypoxemia in formation of upper limb muscle dysfunction in case of chronic obstructive lung disease. Pacific medical journal. 2012;1(47):90-2 (In Russ.). Available at: https://elibrary.ru/item.asp?id=22670355
18. Remels AHV, Gosker HR, Langen RCJ, Schols AMWJ. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Applied Physiology. 2012;114(9):1253-62. http://dx.doi.org/10.1152/japplphysiol. 00790.2012
19. Ciciliot S, et al. Muscle type and fiber type specificity in muscle wasting. The International J Biochemistry & Cell Biology. 2013;45(10):2191-9. http://dx.doi.org/10.1016/j.biocel.2013.05.016
20. Clanton TL, Levine S. Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? J Applied Physiology. 2009;107(1):324-35. http://dx.doi.org/10.1152/japplphysiol.00173.2009
21. Barreiro E, Gea J. Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease. Chronic Respiratory Disease. 2016;13(3):297-311. http://dx.doi.org/10.1177/147 9972316642366
22. Cojocaru C, et al. A biological perspective for the management of chronic obstructive pulmonary disease by testosterone. Archives of Biological Sciences. 2015;67(1):257-9. http://www.doiserbia.nb.rs/img/ doi/0354-4664/2015/0354-46641400035C.pdf
23. Goncharov NP, Katsiya GV. Dehydroepiandrosterone biosynthesis, metabolism, biological effects, and clinical use (analytical review). Andrology and Genital Surgery. 2015;16(1):13-22 (In Russ.). doi: 10.17650/2070-9781-2015-1-13-22
24. Levin OS, Polunina AG, Demyanova MA, Isaev FV. Steroid myopathy in patients with chronic respiratory diseases. J Neurological Sciences. 2014;338(1-2):96-101. http://dx.doi.org/10.1016/j.jns.2013.12. 023
25. Mantilla CB, Sieck GC. Impact of diaphragm muscle fiber atrophy on neuromotor control. Respiratory Physiology & Neurobiology. 2013;189(2):411-8. http://dx.doi.org/10.1016/j.resp.2013.06.025
26. Laveneziana P, Webb KA, Wadell K, Neder JA, O’Donnell DE. Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD? Respiratory Physiology & Neurobiology. 2014;199:24-33. http://dx.doi.org/10.1016/j.resp.2014.04.005
27. Weatherald J, Lougheed MD, Taillé C, Garcia G. Mechanisms, measurement and management of exertional dyspnoea in asthma. European Respiratory Review. 2017;26(144):170015. http://dx.doi.org/ 10.1183/16000617.0015-2017
28. Moukharliamov FYu, Sytcheva MG, Rassulova MA. Training of respiratory muscles on the normocapnic hyperventilation method at patients with the chronic obstructive lung disease and bronchial asthma. Bulletin of Pirogov National Medical & Surgical Center. 2015;10(3):109-12 (In Russ.). Available at: https://elibrary.ru/download/elibrary_2650 8445_19489 114.pdf
29. Barkova AV, et al. Parameters of activity of local and systemic inflammation in patients with bronchial asthma women without exacerbation of the disease. Uchenye zapiski Saint Petersburgskogo gosudarstvennogo medicinskogo universiteta imeni akademika IP. Pavlova. 2016;23(3):47-51 (In Russ.). Available at: https://elibrary.ru/download/elibrary_28361330_96401650.pdf
30. Pereira LFF, Mancuzo EV, Rezende CF, Côrrea RA. Six-minute walk test and respiratory muscle strength in patients with uncontrolled severe asthma: a pilot study. J Brasileiro de Pneumologia. 2015;41(3):211-8. http://dx.doi.org/10.1590/s1806-37132015000004483
31. Ramos E, de Oliveira LV, Silva A, Costa I, Corrêa JC, Costa D, et al. Peripheral muscle strength and functional capacity in patients with moderate to severe asthma. Multidisciplinary Respiratory Medicine. 2015;10(1):3-10. http://dx.doi.org/10.1186/2049-6958-10-3
32. Aguiar KA, et al. A single section of stretch of the respiratory muscles does not influence the pulmonary volume of asthmatics during exercise. J Respiratory and Cardiovascular Physical Therapy. 2016;3(1):3-13. Available at: https://www.researchgate.net/profile/ntonio_Sarmento3/publication/301541319_A_Single_Section_of_Stre...
33. Gimeno-Santos E, Fregonezi GA, Torres-Castro R, Rabinovich R, Vilaró J. Inspiratory muscle training and exercise versus exercise alone for asthma. Cochrane Database of Systematic Reviews. 2015;7:1-10. http://dx.doi.org/10.1002/14651858.cd011794
34. Kuznetsov NA, Luberto CM, Avallone K, Kraemer K, McLeish AC, Riley MA. Characteristics of postural control among young adults with asthma. J Asthma. 2014;52(2):191-7. http://dx.doi.org/10.3109/ 02770903.2014.954290
35. Bodine SC, Furlow JD. Glucocorticoids and Skeletal Muscle. Glucocorticoid Signaling. 2015:145-76. Available from: http://dx.doi.org/ 10.1007/978-1-4939-2895-8_7
36. Polunina AG, Isaev FV, Demianova MA. Steroid-induced myopathy. Neuroscience and behavioral physiology. 2012;112(10):60-4 (In Russ.). Available at: https://www.researchgate.net/profile/Anna_Polunina/publication/233949279_Steroidnaa_miopatia/links/0...
37. Teodorescu M, Xie A, Sorkness CA, Robbins J, et al. Effects of Inhaled Fluticasone on Upper Airway during Sleep and Wakefulness in Asthma: A Pilot Study. J Clinical Sleep Medicine. 2014;10(2):183-93. http://dx.doi.org/10.5664/jcsm.3450
38. Qiao H, Cheng H, Liu L, Yin J. Potential factors involved in the causation of rhabdomyolysis following status asthmaticus. Allergy, Asthma & Clinical Immunology. 2016;12(1):1-7. http://dx.doi.org/10.1186/ s13223-016-0149-6
39. He Y, Shi J, Yi W, Ren X, et al. Discovery of a highly potent glucocorticoid for asthma treatment. Cell Discovery. 2016;2:150-63. http://dx.doi.org/10.1038/celldisc.2015.51
40. Verschakelen J, Vock P. Diseases of the Chest Wall, Pleura, and Diaphragm. Diseases of the Heart, Chest & Breast. 2015:99-103. http://dx.doi.org/10.1007/978-88-470-0633-1_17
41. Tochino Y, et al. Asthma‐COPD overlap syndrome—Coexistence of chronic obstructive pulmonary disease and asthma in elderly patients and parameters for their differentiation. J General and Family Medicine. 2017;18(5):5-11. Available at: http://onlinelibrary.wiley.com/ doi/10.1002/jgf2.2/epdf
42. José A, Dal Corso S. Inpatient rehabilitation improves functional capacity, peripheral muscle strength and quality of life in patients with community-acquired pneumonia: a randomised trial. J Physiotherapy. 2016;62(2):96-102. http://dx.doi.org/10.1016/j.jphys. 2016.02.014
43. Ageeva TS, et al. Clinico-scintigraphic characteristics and oxidation in community-acquired pneumonia: correlations with severity of pulmonary tissue infiltrative lesion. Therapeutic Archive. 2011;83(3):31-7 (In Russ.). Available at: https://elibrary.ru/item.asp?id=16373885
44. Geltser BI, Kim AP, Kotelnikov VN, Makarov AB. Features of immune response in patients with community-acquired pneumonia with endogenous intoxication of different degrees of severity. Cytokines and Inflammation. 2015;14(3):35-41 (In Russ.). Available at: https://elibrary.ru/item.asp?id=26511105
45. Somov DA, Makarova MR, Makarova IN. The importance of muscular disbalance for the development of the system of therapeutic physicalexercises to treat the patients presenting with pneumonia. Voprosy kurortologii, fizioterapii i lechebnoy fizicheskoy kul’tury. 2015;92(3):7-10 (In Russ.). Available at: https://www.mediasphera.ru/issues/voprosy-kurortologii-fizioterapii-i-lechebnoj-fizicheskoj-kultury/...
46. Musher DM, Thorner AR. Community-acquired pneumonia. New England J Medicine. 2014;371(17):1619-28. doi: 10.1056/NEJ Mra1312885
47. Faverio P, et al. The management of community-acquired pneumonia in the elderly. Eur J Intern Med. 2014;25(4):312-9. http:// dx.doi.org/10. 1016/j.ejim.2013.12.001
48. Murad A, Li PZ, Dial S, Shahin J. The role of noninvasive positive pressure ventilation in community-acquired pneumonia. J Critical Care. 2015;30(1):49-54. http://dx.doi.org/10.1016/j.jcrc.2014. 09.021
49. Faisal A, Alghamdi BJ, Ciavaglia CE, Elbehairy AF, Webb KA, Ora J, et al. Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders. Amer J Respiratory and Critical Care Medicine. 2016;193(3):299-309. http://dx.doi.org/10.1164/rccm.201504-0841oc
50. Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y, et al. Prognostic Factors for Myositis-Associated Interstitial Lung Disease. PLoS ONE. 2014;9(6):e98824. http://dx.doi.org/10.1371/journal. pone.0098824
51. Антелава О.А., Бондаренко И.Б., Чичасова Н.В., Насонов E.L. Респираторные нарушения при полимиозите/ дерматомиозите. Современная ревматология. 2014;8(1):31-8 [Antelava OA, Bondarenko IB, Chichasova NV, Насонов EL. Respiratory disorders in patients with polymyositis/ dermatomyositis. Modern Rheumatology J. 2014;8(1):31-8 (In Russ.)]. http://dx.doi.org/10.14412/1996-7012-2014-1-31-38
52. Rygiel KA, Miller J, Grady JP, Rocha MC, et al. Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathology and Applied Neurobiology. 2015;41(3):288-303. http://dx.doi.org/10.1111/nan.12149
53. Carstens PO, Schmidt J. Diagnosis, pathogenesis and treatment of myositis: recent advances. Clinical & Experimental Immunology. 2014;175(3):349-58. http://dx.doi.org/10.1111/cei.12194
54. Walterspacher S, Schlager D, Walker DJ, Müller-Quernheim J, Windisch W, Kabitz H-J. Respiratory muscle function in interstitial lung disease. European Respiratory J. 2012;42(1):211-9. http://dx.doi.org/10. 1183/09031936.00109512
55. Elia D, Kelly JL, Martolini D, Renzoni EA, Boutou AK, Chetta A, et al. Respiratory Muscle Fatigue following Exercise in Patients with Interstitial Lung Disease. Respiration. 2013;85(3):220-7. http://dx.doi.org/10.1159/ 000338787
56. Güttsches AK, Balakrishnan-Renuka A, Kley RA, Tegenthoff M, et al. ATOH8: a novel marker in human muscle fiber regeneration. Histochemistry and Cell Biology. 2014;143(5):443-52. http://dx.doi.org/ 10.1007/s00418-014-1299-6
57. Andrews JS, Trupin L, Schmajuk G, Barton J, et al. Muscle Strength, Muscle Mass, and Physical Disability in Women With Systemic Lupus Erythematosus. Arthritis Care & Research. 2014;67(1):120-7. http://dx. doi.org/10.1002/acr.22399
58. Mittoo S, Swigris JJ. Pulmonary Manifestations of Systemic Lupus Erythematosus (SLE). Pulmonary Manifestations of Rheumatic Disease. 2014;35(2):61-72. http://dx.doi.org/10.1007/978-1-4939-0770-0_6
59. Panagiotou M, Polychronopoulos V, Strange C. Respiratory and lower limb muscle function in interstitial lung disease. Chronic Respiratory Disease. 2016;13(2):162-72. http://dx.doi.org/10.1177/1479972315626 014
60. Авдеев С.Н. Идиопатический фиброз легких: новая парадигма. Терапевтический архив. 2017;89(1):112-22 [Avdeev SN. Idiopathic pulmonary fibrosis. Therapeutic Archive. 2017;89(1):112-22 (In Russ.)]. http://dx.doi.org/10.26442/20 75- 1753_19.3.17-23
61. Marcellis RGJ, Lenssen AF, Elfferich MDP, De Vries J, et al. Exercise capacity, muscle strength and fatigue in sarcoidosis. European Respiratory J. 2011;38(3):628-34. http://dx.doi.org/10.1183/0903 1936.00117710
62. Kesici B, Toros AB, Bayraktar L, Dervisoglu A. Sarcoidosis Incidentally Diagnosed: A Case Report. Case Reports in Pulmonology. 2014;2014:1-3. http://dx.doi.org/10.1155/2014/702868
63. Nowinski A, et al. Comorbidities associated with sarcoidosis–Results from long-term observational study. European Respiratory J. 2014;44(58):461. Available at: http://erj.ersjournals.com/content/44/ Suppl_58/P461.short
64. Celada LJ, Hawkins C, Drake WP. The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis. Clinics in Chest Medicine. 2015;36(4):561-8. http://dx.doi.org/10.1016/j.ccm.2015.08.001
1 ФГАОУ ВО «Дальневосточный федеральный университет» Минобрнауки России, Владивосток, Россия;
2 ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава России, Владивосток, Россия
________________________________________________
B.I. Geltser 1,2, I.G. Kurpatov 2, A.A. Dej 1, A.G. Kozhanov 1
1 Far Eastern Federal University of the Ministry of Education and Science, Vladivostok, Russia;
2 Pacific State Medical University of the Ministry of Health of the Russian Federation, Vladivostok, Russia